ARCHIVES

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial

May 27, 1994

Dana-Farber Opens Imaging Center

May 8, 2009

FDA Grants Accelerated Approval to Imbruvica

November 29, 2013

Researchers Find Genetic Alterations in Triple-Negative Cancers Following Treatment

January 25, 2013

NCI Cooperative Group Clinical Trials Approved

June 26, 2009

Chabner Says Some Group Satellites Causing Concern Because Of Lack Communications

March 4, 1983